EGFR抑制剂ppt课件

.,1,.,2,Introduction,.,3,CellularSignallingPathways,Vitalforcellcycleprogression,growth,differentiation9:5867.2.HerbstR.S,FukuokaM,BaselgaJ.Gefitinibanoveltargetedapproachtotreatingcanver.Naturerevcancer2004;4:95665.3.StrausbergR.L,SimpsonA.J.G,OldL.J,RigginsG.J.Oncogenomicsandthedevelopmentofnewcancertherapies.Nature2004;429:46974.4.NobleM.E.M,EndicottJ.A,JohnsonL.N.Proteinkinaseinhibitors:Insightsintodrugdesignfromstructure.Science2004;303:180005.5.GloverK.Y,SolerR.P,PapadimitradopoulouV.A.AreviewofsmallmoleculeEpidermalGrowthFactorReceptorspecifictyrosinekinaseinhibitorsindevelopmentfornonsmallcelllungcancer.Sem.Oncol.2004;31suppl:8392.6.JanmaatM.L,GiacconeG.SmallmoleculeEpidermalGrowthFactorReceptortyrosinekinaseinhibitors.Oncologist2003;8:57686.,.,39,ReviewArticlescont,7.YanoS,NishiokaY,GotoH,SoneS.Molecularmechanismofangiogenesisinnonsmallcelllungcancerandtherapeuticstragetingrelatedmolecules.Cancersci.2003;94:47985.8.VlahovicG,CrawfordJ.Activationoftyrosinekinasesincancer.Oncologist2003;8:5318.9.SpiroS.G,PorterJ.C.Lungcancerwherearewetoday?Currentadvancesinstagingandnonsurgicaltreatment.AmJRespirCritCareMed2002;166:116696.10.ArteagaC.L,EpidermalGrowthFactorReceptordependenceinhumantumors:morethanjustexpression?Oncologist2002;7suppl4:319.11.RaymondE,FaivreS,ArmandJ.P.Epidermalgrowthfactorreceptortyrosinekinaaseasatargetforanticancertherapy.Drugs2000;60suppl1:1523.,.,40,MiniReview,1.LevinE.R.Bidirectionalsignallingbetweentheestrogenreceptorandtheepidermalgrowthfactorreceptor.Mol.Endocrinol.2003;17:30917.,OriginalArticles,KellyK,AverbuchS.Gefitinib:PhaseIIandIIIresultsinadvancednonsmallcelllungcancer.Sem.Oncol.2004;31suppl1:939.PaoW,WangT,RileyG.J,MillerV.A,PanQ,VarmusH.Eetal.KRASmutationsan